[VIEW] agent=Risk & Compliance Officer | scenario_id=120 | rounds=20

--- Round 0 ---
[R0.1] Risk & Compliance Officer (speak, public): To evaluate the feasibility of launching the pharmacist-led telehealth anticoagulation management service, I would like to understand the expected clinical outcomes and operational capacity from a clinical perspective. Additionally, can you provide insights on how we plan to align funding and incentives for this service?
[R0.2] Pharmacy Clinical Lead (Anticoagulation Services) (speak, public): The pilot outcomes from our telehealth anticoagulation management service show significant improvements, with an increase in the time in therapeutic range (TTR) from 52% to 68% across 180 patients in two clinics. Additionally, our enrollment funnel indicates that we have 640 eligible patients per quarter, with a current enrollment rate of 28%. For operational capacity, we typically require 1.8 pharmacist FTEs and 0.6 RN FTEs per 500 active patients to manage this service effectively. As for funding and incentives, we should consider aligning our reimbursement model with payer expectations to ensure sustainability. I would recommend a follow-up discussion to delve deeper into the regulatory and financial aspects with the Payer Contracting & Finance Manager.
[R0.3] Payer Contracting & Finance Manager (speak, public): Based on the reimbursement model, we are looking at a per-episode reimbursement of $62 with a projected volume of 9,600 episodes per year. This aligns with our program's financial viability, but we need to ensure that the operational capacity, particularly regarding staffing intensity, is manageable with the 1.8 pharmacist FTEs and 0.6 RN FTEs per 500 active patients. Also, we should examine if there are any potential hidden patient-safety exposures that we need to be aware of in the clinical protocol. Let’s discuss how we can align these insights with our funding and incentive strategies.

--- Round 1 ---
[R1.1] Risk & Compliance Officer (speak, private to=Pharmacy Clinical Lead (Anticoagulation Services),Payer Contracting & Finance Manager): I appreciate the insights on clinical outcomes and financial viability. Regarding patient safety, I recommend we ensure that our protocols include robust risk assessments and contingency plans to handle any unforeseen issues. This will help in mitigating potential exposures that could affect funding and compliance. Let’s also outline the operational protocols to address any high-risk clinical situations in detail, as this is crucial for our overall assessment. Can we schedule a follow-up meeting to dive deeper into these aspects?
[R1.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R1.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 2 ---
[R2.1] Risk & Compliance Officer (leave, public): 
[R2.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R2.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 3 ---
[R3.1] Risk & Compliance Officer (leave, public): 
[R3.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R3.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 4 ---
[R4.1] Risk & Compliance Officer (leave, public): 
[R4.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R4.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 5 ---
[R5.1] Risk & Compliance Officer (leave, public): 
[R5.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R5.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 6 ---
[R6.1] Risk & Compliance Officer (leave, public): 
[R6.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R6.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 7 ---
[R7.1] Risk & Compliance Officer (leave, public): 
[R7.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R7.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 8 ---
[R8.1] Risk & Compliance Officer (leave, public): 
[R8.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R8.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 9 ---
[R9.1] Risk & Compliance Officer (leave, public): 
[R9.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R9.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 10 ---
[R10.1] Risk & Compliance Officer (leave, public): 
[R10.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R10.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 11 ---
[R11.1] Risk & Compliance Officer (leave, public): 
[R11.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R11.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 12 ---
[R12.1] Risk & Compliance Officer (leave, public): 
[R12.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R12.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 13 ---
[R13.1] Risk & Compliance Officer (leave, public): 
[R13.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R13.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 14 ---
[R14.1] Risk & Compliance Officer (leave, public): 
[R14.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R14.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 15 ---
[R15.1] Risk & Compliance Officer (leave, public): 
[R15.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R15.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 16 ---
[R16.1] Risk & Compliance Officer (leave, public): 
[R16.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R16.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 17 ---
[R17.1] Risk & Compliance Officer (leave, public): 
[R17.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R17.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 18 ---
[R18.1] Risk & Compliance Officer (leave, public): 
[R18.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R18.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 19 ---
[R19.1] Risk & Compliance Officer (leave, public): 
[R19.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R19.3] Payer Contracting & Finance Manager (leave, public): 

